Skip to search.

Breaking News Visit Yahoo! News for the latest.

×Close this window

 Dow Up0.06% Nasdaq Down0.01%

ARCA biopharma, Inc. (ABIO)

-NasdaqCM

2.66 Up 0.10(3.91%) 3:59PM EDT

Add to Portfolio
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingDec 30, 2012Dec 30, 2011Dec 30, 2010
Total Revenue -   -   -  
Cost of Revenue -   -   -  
Gross Profit -   -   -  
Operating Expenses
Research Development1,092  2,315  3,106  
Selling General and Administrative3,227  5,046  6,069  
Non Recurring -   -   -  
Others -   -   -  
Total Operating Expenses -   -   -  
Operating Income or Loss (4,319) (7,361) (9,175)
Income from Continuing Operations
Total Other Income/Expenses Net2  2,002  763  
Earnings Before Interest And Taxes(4,317)(5,359)(8,412)
Interest Expense3  5  8  
Income Before Tax(4,320)(5,364)(8,420)
Income Tax Expense -   -   -  
Minority Interest -   -   -  
Net Income From Continuing Ops(4,320)(5,364)(8,420)
Non-recurring Events
Discontinued Operations -   -   -  
Extraordinary Items -   -   -  
Effect Of Accounting Changes -   -   -  
Other Items -   -   -  
Net Income (4,320) (5,364) (8,420)
Preferred Stock And Other Adjustments -   -   -  
Net Income Applicable To Common Shares (4,320) (5,364) (8,420)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.